Be Part of Europe’s Leading Life Sciences IP Think Tank

By bringing the collective knowledge and practical experiences of leading in-house IP counsel, patent prosecutors and litigators, the EPO, Munich Patent Court, and policy experts from around the world, C5’s Life Sciences IP Summit 2019 will provide you with comprehensive knowledge and benchmarking opportunities to ensure that you are leading the way in patent protection for your company and clients.

This must attend event is designed specifically for Intellectual Property Attorneys and Strategists, Senior Counsel, and Directors of IP operating within the pharmaceutical and biotech industries.


Conference Co-Chairs:

Paul Inman

Partner
Gowlings WLG (U.K)

Dr. Corinna Sundermann

Senior Vice President, Intellectual Property Management
Fresenius Kabi Deutschland GmbH (Germany)
Read the Q&A with Dr. Corinna Sundermann on IP Trends and Challenges


A View from the Bench with:

Martin Jäger

Judge
German Federal Patent Court


Learn from Key Industry Leaders:

Kristin Cooklin

Global Head of Patents
Zentiva

Fredrik Fredh

Senior Patent
Attorney Novartis

Andreas Geissler

VP Intellectual Property
Leukocare AG

Bernd Hutter

Vice President, Head of Intellectual Property
MorphoSys

 

John Kirkland

Director, IP & Litigation Counsel
Alkermes

Karin Pramberger

Intellectual Property Director
Swiss Pharma International

Alastair Sayce

Head of Biologics IP
Teva Pharmaceuticals

Dr. Corinna Sundermann

Senior Vice President, Intellectual Property Management
Fresenius Kabi Deutschland GmbH


New Focus Sessions on:

  • Product Lifecycle Management: Analysing the Interplay of IP Protection Tools Available Beyond Patents and SPC
  • SPC Applications featuring a Q&A with In-House Counsel: Practical Advice on How to Succeed in the SPC Application Process in the Light of Recent Developments
  • Controversies Surrounding the Patentability of Gene-Editing Processes
  • And 2 NEW Pre-conference workshops
    • A International Secondary Medical Use Patenting Strategy
    • B International Biosimilars Think Tank

What have previous attendees said about this Summit?

“Another great C5 conference. Good variety of attendees and topics.”

Robin Ellis, Head of IP Product, Sandoz

“Good meeting; I enjoyed it a lot, including both the talks and the social side.”

Andrew Bentham, Patent Attorney, JA Kemp

“Again, very good speakers from all over Europe and the US!”

Chrisoph Rehfuss, Head of IP, Sotio

Past Attending Companies:

  • Ablynx NV
  • Alkermes Pharma Ireland Ltd
  • AstraZeneca AB
  • Benitec Biopharma Limited
  • Biotronik
  • Boehringer Ingelheim
  • Celltrion
  • Chiesi Farmaceutici Spa
  • EGIS Pharmaceuticals PLC
  • Esteve Group
  • European Patent Office
  • F. Hoffmann-La Roche Ltd
  • Federal Agency for Nature
  • Finnish Patent and Registration Office
  • Fresenius Medical Care AG & Co
  • Fresenius Medical Care AG & Co. KG Aa
  • Geistlich Pharma AG
  • Genmab AS
  • German Patent & Trade Mark Office
  • GlaxoSmithKline
  • Groupe Sanofi
  • Helsinn Healthcare SA
  • JETRO Duesseldorf
  • Leukocare AG
  • Linde Healthcare
  • Merus NV
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • PARI Pharma GmbH
  • Patent Office Denmark
  • Patents Office Ireland
  • Sandoz International GmbH
  • Sanofi-Aventis Deutschland GmbH
  • Silence Therapeutics Plc
  • Swiss Federal Institute of Intellectual Property
  • Teva Pharmaceuticals Ltd
  • TiGenix NV
  • UCB Chong Kun Dang pharm.
  • Valea AB
  • Zacco Denmark AS
  • Zealand Pharma AS
  • Zentiva Group

Past Attendees by Country:

Past Attendees by Country


Best Rates Expiring Soon. Register today and join your peers at the global Life Sciences community’s leading IP event!

 


 

Event Contacts

For sponsorship opportunities please contact:

C5 (UK)
E: sponsorinfo@c5-online.com

For information about the program and speaking opportunities please contact:

Alistair Ren-Healey
P: +44 (0) 20 7878 6955
E: speakeropportunity@c5-online.com

Connect With Us!

Join the Conversation

@C5Live
#C5LifeScience